Treatment Advances and Evolving Standard of Care in Atopic Dermatitis - Episode 12
Monitoring Schedule for JAK Inhibitors in Atopic Dermatitis
Lindsay S. Ackerman, MD, FAAD, and Jonathan Silverberg, MD, PhD, MPH, provide clinical insights on best practices for monitoring patients with atopic dermatitis who are receiving JAK inhibitors.
Video content above is prompted by the following:
- What is the recommended monitoring schedule for JAKi? Do you communicate it with patients when selecting treatment?
